Introduction: Aldosterone plays an important role in the pathogenesis of non-familial atrial fibrillation (AF). We tested the hypothesis that the −344T/C polymorphism in the aldosterone synthase gene may be associated with non-familial AF in Chinese patients with hypertension.
Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in clinical practice and is associated with increased cardiovascular mortality and morbidity, e.g. stroke and heart failure. 1 The underlying mechanisms for AF are multiple and not conclusive. It is clear that genetic predisposition may account for certain proportion of AF. 2 In addition to familial AF, genetic variation could contribute to the susceptibility to non-familial AF, which often occurs in association with hypertension, coronary heart disease, valvular heart disease, and heart failure. 3 Genes encoding ion channels, angiotensinogen and angiotensin converting enzyme (ACE) are strong candidates. [4] [5] [6] As a member of renin-angiotensin-aldosterone (RAS) system, aldosterone is the principal mineralocorticoid hormone. In addition to regulating sodium balance and volume homeostasis, aldosterone also plays a major role in the cardiac fibrosis and remodeling, 7, 8 and cardiovascular diseases. 9 Recent reports suggest that AF is associated with activation of aldosterone in atria; 10, 11 blockade of the aldosterone receptor using spironolactone could prevent the incidence of AF induced by tachypacing in dogs. 12 Thus aldosterone may be involved in atrial structural and electrical remodeling and blockade of the aldosterone receptor may affect the pathogenesis of AF and offer a novel therapeutic target for AF.
Human aldosterone synthase (CYP11B2) is a cytochrome P450 enzyme, which catalyses the terminal steps of aldosterone biosynthesis, 13 hence affects development of cardiovascular disease. A common single nucleotide polymorphism, C to T transition at the position −344 bp occurs within the promoter region of CYP11B2. 14 Although its functional significance and clinical implication are still controversial, some studies suggest that this polymorphism is associated with increased constitutive aldosterone production, 14, 15 which subsequently leads to cardiac fibrosis and remodeling. It is therefore one of the molecular targets for the pathogenesis of essential hypertension, [16] [17] [18] left ventricular hypertrophy [19] [20] [21] and heart failure. 22 It is uncertain, however, whether the −344T/C polymorphism of the CYP11B2 gene encoding for aldosterone synthase is associated with non-familial AF. Some studies suggested that the polymorphism may be linked to cardiac remodeling [19] [20] [21] and hypertension, [16] [17] [18] which are both strongly linked to the incidence of AF. Therefore, in the current study we investigated the relationship of this genetic variant with AF in Chinese hypertensive patients.
Materials and methods

Subjects and clinical assessment
Three hundred and ten cases of essential hypertension (EH) patients with a documentation of AF were consecutively recruited. For every case patient, a matched EH patient without AF was selected in the same period as control. The two groups of the patients were individually matched with regard to their gender and age (difference ±5 years). All subjects enrolled in this study were native Chinese and from the general Clinic and Cardiology Division in Yuhuangding Hospital of Qingdao University from August 2007 to November 2010. The study protocol was approved by the local ethics committee, and informed consent was obtained from each subject. Exclusion criteria for subjects were the presence of secondary hypertension, familial AF, myocardial infarction, systolic heart failure (left ventricular ejection fraction < 45%), congenital heart disease, cardiomyopathy, valvular heart disease, moderate to severe mitral regurgitation, obstructive pulmonary disease and hyperthyroidism.
Hypertension was defined as subjects receiving antihypertensive drugs and /or systolic blood pressure exceeding 140 mmHg and/or diastolic blood pressure exceeding 90 mmHg on at least two consecutive visits. The subjects' blood pressure was measured with sphygmomanometer in the sitting position after resting for at least 15 min. The AF was diagnosed by serial 12-lead electrocardiography (ECG) and/or 24-h Holter monitoring. Patients with episodes of palpitation but without ECG documentation of AF were excluded from both groups. M-mode and two-dimensional transthoracic echocardiography were performed after enrolment to measure left atrial and left ventricular dimensions, left ventricular ejection fraction (LVEF) was assessed by the Simpson method, and left ventricular mass was calculated with echocardiographic parameters and the Devereux formula.
Determination of genotype
The genotype of −344T/C polymorphism in the CYP11B2 gene was determined by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. 13 Briefly, genomic DNA was isolated from peripheral leukocytes using a Puregene ® DNA purification kit (Gentra Systems, Minneapolis, USA). A DNA segment of CYP11B2 gene covering from −548 bp to −11 bp was amplified by a GoTaq ® PCR Core Systems (Promega, Madison, USA) using a pair of primers (5′-CAGGAGGAGACCCCATGTGAC-3′, and 5′-CCTCCACCCTGTTCAGCCC-3′). The thermal cycling condition was initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturing at 94°C for 1 min, annealing at 67° for 1 min, and extension at 72°C for 2 min. An aliquot of PCR products was digested with the HaeIII restriction enzyme and then subjected to electrophoresis on a 2.0% agarose gel and visualized under ultraviolet light. HaeIII digestion of the 538 bp PCR product yielded 273 bp plus small fragments of less than 150 bp in the T allele while 202 bp plus small fragments were detected in the C allele for the existence of an additional recognition site of HaeIII.
Statistical analysis
Continuous data was presented as mean ± SD. Distribution of genotypes and frequency of alleles were calculated and compared using the χ 2 test. Clinical characteristics between the two groups were compared by the independent Student's t test for continuous data and by the χ 2 test for categorical data. Hardy-Weinberg equilibrium was evaluated by the χ 2 test in both groups. Logistic regression analysis was used to identify the independent predictive variables for AF, odds ratios for the presence of AF and 95% confidence intervals were estimated. A two-tailed p < 0.05 was deemed to be statistically significant. The statistical analysis was performed using the 15.0 SPSS software.
Results
Clinical characteristics
The overall clinical characteristics of the subjects are listed in Table 1 . No significant differences were found between the two groups with respect to age, blood pressure, gender distribution, frequency of diabetes and smoking or drinking habit (all p > 0.05). The left atrial dimension (LAD) was significantly larger in patients with AF than that in the controls (p < 0.001). Likewise, the interventricular septal (IVS) thickness, left ventricular end diastolic dimension (LVEDD) and left ventricular mass were also significantly greater in patients with AF than that in the controls (p < 0.001). Left ventricular posterior wall (LVPW) thickness and LVEF were not significantly different between the two groups (p > 0.05).
Association between −344T/C variants and atrial fibrillation
An example of the three different genotypes was shown in Figure 1 . Table 2 shows the distribution of genotypes and frequency of alleles for the −344T/C CYP11B2 gene polymorphism. The polymorphism −344C/T did not exhibit significant deviation from Hardy-Weinberg expectations in the patients with AF or without AF. The distribution of the CYP11B2 genotypes (TT, TC and CC) was 41.9%, 50.6%, and 7.4% in AF patients, 48.4%, 44.5% and 7.1% in non-AF patients, respectively (χ 2 = 2.675, p = 0.263). The frequencies of the rare CYP11B2 C allele were not significantly different between the AF patients (32.3%) and non-AF patients (29.4%) (χ 2 = 1.661, p = 0.197).
Logistic regression analyses revealed that LAD and LVEDD were independent predictors of AF (both p < 0.001) ( Table 3 ). The OR for AF in the C allele carrier was 1.30 (95% CI 0.95-1.78, p = 0.107) in the logistic regression analysis and 1.13 (95% CI 0.72-1.78, p = 0.601) after adjusting for LAD and LVEDD. These results indicated that no statistically significant association between AF and −344T/C polymorphism of CYP11B2 was found in this population. 
The echocardiographic parameters of different genotypes
For a small number of CC genotypes in our study we took the TC and CC genotypes as one group of C allele carriers. The LAD of C allele carriers was significantly larger than that of non-C allele carriers (p = 0.009) but no significant difference was found in LVPW, IVS, LVEDD and LV mass between two groups.
Discussion
It has been reported that the left atrial diameter is an independent risk of AF. In our study, besides the left atrial diameter, the IVS, LVEDD and LV mass of the AF group are also larger than that of non-AF patients. These results of the clinical characteristics support the idea that the remodeling of the whole heart, not only left atrial remodeling, may play an important role in the incidence of AF. Our study showed a lack of an association between the −344T/C polymorphism in the aldosterone synthase gene and AF in patients with essential hypertension in Chinese subjects. Logistic regression analysis demonstrated that LAD and LVEDD, rather than the C allele of the CYP11B2 gene, were the significant predictors of AF in Chinese hypertensive patients. Although −344C/T polymorphism has been widely studied, especially in Japanese 16, 17, 23 and Caucasians, 24 its functional significance and clinical implications are still uncertain. The −344C/T polymorphism in the aldosterone synthase gene, which is located at a putative binding site for the steroidogenic transcription factor (SF-1), has been demonstrated to affect the transcription of CYP11B2 in vitro, the −344C allele binds the SF-1 four times more than the T allele, 14 and has been linked to increased aldosterone production as well as increased serum aldosterone level, 15 whereas work by others showed that the T allele is associated with higher gene espression 25 and higher aldosterone excretion rate than the C allele, 26, 27 even in some studies no positive correlation was found between plasma aldosterone and −344C/T polymorphism. 24, 28 The association studies of −344C/T polymorphism with cardiovascular diseases are also inconsistent, even in the same ethnic group. Tamaki et al. 16 reported that the −344 C allele of the CYP11B2 gene may be a genetic marker for low-renin hypertension in Japanese while the Suita Study found a lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese. 23 Zhu et al. 29 reported contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites from London. None of the variants in the CYP11B2 gene was associated with essential hypertension in the black subjects; but there was a significant association between the T allele and essential hypertension in the white participants. Significant associations between the risk of hypertension and the CC genotype or C allele frequencies were found in some but not all studies conducted in Chinese. 18 In addition, C allele frequency was found to be lower in southern Chinese than in their northern counterparts. 18 The genotype and allele frequency of the −344C/T variant between populations of different ethnicities is very different. In some ethnicities, for example in Japanese and northern Chinese, the C allele is the rare allele and the frequency is less than 40%, but in Caucasians the frequency of the C allele is more than 50% and higher than T allele frequency. 24 A study conducted in Great Britain showed that the frequency of the C allele was significantly lower in people of African origin (21%) than in white (46%) and South Asian (43%) subjects. 27 These interesting findings might suggest a feasible explanation for a large inter-racial difference in association studies of −344C/T polymorphism with cardiovascular diseases.
It is known that the renin-angiotensin-aldosterone system (RAAS) plays an important role as a mediator of atrial remodeling in AF. 30 Recent reports, [31] [32] [33] some of which are controversial, suggested that suppression of RAAS activity by adjunctive use of ACE inhibitors or angiotensin receptor antagonists had a greater probability of maintaining patients as AF free, which is most likely mediated by preventing the constitution of the arrhythmic substrate. Increased levels of aldosterone have been implicated in the remodeling of the extracellular matrix of the myocardium by increased collagen biosynthesis and cardiomyocyte apoptosis. 7, 8 Studies have also shown that aldosterone could induce marked structural remodeling of atria in some animal models. 11, 12 Milliez et al. 11 demonstrated that spironolactone, a type of aldosterone receptor antagonist, can attenuate the atrial fibrosis and left atrial diameter in rat model. These results indicate that aldosterone may be involved in the mechanism of atrial structural and electrical remodeling, and that blockade of the cardiac aldosterone receptor may affect the pathophysiological substrate of AF, which offers a new therapeutic approach to AF.
It has been demonstrated that the CYP11B2 gene is expressed in human cardiovascular tissue, so that high expression of the aldosterone synthase gene may cause a high tissue aldosterone concentration, which subsequently causes atrial fibrosis, conduction heterogeneity and increased the substrate for the development of AF. Some studies suggest that −344T/C polymorphisms of CYP11B2 may be linked to hypertension [16] [17] [18] and cardiac hypertrophy, [19] [20] [21] which are both strongly linked to the incidence of AF. Therefore, we hypothesized that the C allele of CYP11B2 might be related to AF susceptibility in hypertension. In this study we investigated a selected population of hypertension patients of northern Chinese with or without AF. Our data demonstrated that the remodeling of heart, e.g. the size of left atrium and left ventricle, but not the −344C/T polymorphism, are significant predictors for AF.
Currently, available reports about an association between the −344C/T polymorphism and AF are very limited and inconsistent. Amir et al. 34 found the −344 CC genotype to be a strong independent marker for AF in heart failure. However, another study did not find any relationship between −344 C/T CYP11B2 polymorphism and AF in a cohort of hypertensive patients. 35 Besides the sample size, difference of cardiovascular disease and ethnicity may explain the different result. In order to detect mild or moderate associations in the multifactorial disease of AF, effort should be made to match the subjects carefully with known confounding variables (e.g. ethnicity, age, sex, smoking, accompany cardiovascular disease, etc.) and it becomes evident that large population-based studies are required.
Another finding of our study is the correlation between genotypes and left atrial diameter, which suggested the −344C/T polymorphism may affect the structural remodeling process of atrium. Tsai et al. 10 also reported that aldosterone could induce atrial remodeling through a genomic pathway, which could be attenuated by spironolactone. These results suggest that aldosterone may be involved in the pathophysiological process of atrial remodeling and may provide insight into the treatment consideration for AF with different genotypes.
In conclusion, our finding showed a lack of association between −344T/C polymorphism in aldosterone synthase gene and non-familial AF but this polymorphism might be associated with atrial remodeling in patients with hypertension. A larger clinical study or experimental investigation may be needed to confirm the role of aldosterone synthase in non-familial AF and indeed the role of genetic variant in the aldosterone synthase gene in AF.
